{"id":2276,"date":"2022-08-26T16:06:14","date_gmt":"2022-08-26T20:06:14","guid":{"rendered":"https:\/\/wpdev.acsu.buffalo.edu\/hawklab\/?page_id=2276"},"modified":"2026-02-12T20:45:08","modified_gmt":"2026-02-12T20:45:08","slug":"evarquit","status":"publish","type":"page","link":"https:\/\/ubwp.buffalo.edu\/hawklab\/evarquit\/","title":{"rendered":"EVarQuit"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"2276\" class=\"elementor elementor-2276\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-22c6fff elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"22c6fff\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1591495\" data-id=\"1591495\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f8e6337 elementor-widget elementor-widget-heading\" data-id=\"f8e6337\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">EVarQuit<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d648fed elementor-widget elementor-widget-text-editor\" data-id=\"d648fed\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"font-weight: 400\">The EVarQuit2 trials is the latest in a programmatic series of clinical trials led by Dr. Hawk. The overarching goal is to use basic learning principles to enhance quit smoking rates. \u00a0Specifically, we are evaluating the degree to which increasing the duration of medication people take before they try to quit smoking: (a) extinguishes smoking reinforcement during the pre-quit period and (b) helps people to quit and stay abstinent. It\u2019s a straightforward treatment adaptation that can be readily implemented.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-205efc9 elementor-widget elementor-widget-text-editor\" data-id=\"205efc9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>The primary outcomes manuscript can be found here:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e6d59c3 elementor-widget elementor-widget-text-editor\" data-id=\"e6d59c3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Hawk, L.W., Jr., Tiffany, S.T., Colder, C.R., Ashare, R.L., Wray, J.M., Tyndale, R.F., Brandon, T.H., &amp; Mahoney, M.C. (2022). Effect of extending the duration of pre-quit treatment with varenicline on smoking abstinence: A randomized clinical trial. <i>JAMA Network Open<\/i>, 5(11):e2241731<i>.<\/i><a title=\"Original URL: https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2798316 Click to follow link.\" href=\"https:\/\/nam12.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fjamanetwork.com%2Fjournals%2Fjamanetworkopen%2Ffullarticle%2F2798316&amp;data=05%7C02%7Cgjmerlo%40buffalo.edu%7C95a95c4729a54c904e3508dc8bd0e5f6%7C96464a8af8ed40b199e25f6b50a20250%7C0%7C0%7C638538976544877039%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=z%2FR7XsL8G4I3oi4kWeJC3OI6bjm6z2tfwjFL6M4QFkA%3D&amp;reserved=0\" data-outlook-id=\"c9a507e6-eb4a-497f-b6f2-c1ba40a63ff7\"><span style=\"text-decoration: underline\">DOI:10.1001\/jamanetworkopen.2022.41731<\/span><\/a>.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-785c77f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"785c77f\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1e559bc\" data-id=\"1e559bc\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-afaa72e e-transform elementor-widget elementor-widget-text-editor\" data-id=\"afaa72e\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_transform_translateY_effect&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;47&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateX_effect&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateX_effect_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateX_effect_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateY_effect_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateY_effect_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Other data from the EVarQuit2 trial can be found in:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f0155a1 elementor-widget elementor-widget-text-editor\" data-id=\"f0155a1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li>Fronk, G.E., Hawk, L.W., Jr., Cates, A.M., Clark, J.T., Natale, N., &amp; Dahne, J. (2025). Advancing translational science through trial integrity: REDCap-based approaches to mitigating fraud and bias. Journal of Clinical and Translational Science, 9, e252, 1-7. DOI: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41496788\/\"><span style=\"text-decoration: underline\">10.1017\/cts.2025.10176<\/span><\/a>. PMCID: PMC12766503.<\/li><li>Cooper, R.K., Gass, J., Mahoney, M.C., Tiffany, S.T., Colder, C.R., Maguin, E., Schlienz, N.J., Lawson, S.C., Tyndale, R.F., Sandhur, B., &amp; Hawk, L.W., Jr. (2025). Do lab-based assessments of pre-treatment smoking reinforcement and cue-specific craving predict smoking cessation with varenicline? Psychology of Addictive Behaviors, 39(8), 713-722. DOI: <span style=\"text-decoration: underline\"><a href=\"https:\/\/psycnet.apa.org\/record\/2026-45321-001?doi=1\">https:\/\/dx.doi.org\/10.1037\/adb0001081<\/a><\/span>. PMCID: PMC12318362.<\/li><li>Johnstone, S., Cooper, R.K., Mahoney, M.C., Tiffany, S., Brandon, T., Ashare, R.L., Wray, J.M., Tonkin, S., Knapp, K.S., Maguin, E., Colder, C.R., &amp; Hawk, L.W., Jr. (2025).<br \/>Sex-specific mediation of pre-quit smoking reduction: Secondary analysis of a randomized controlled trial extending varenicline preloading. Nicotine &amp; Tobacco Research, 27, 1963-1974. DOI: <span style=\"text-decoration: underline\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40380787\/\">10.1093\/ntr\/ntaf100<\/a><\/span>. PMCID: PMC12539921.<\/li><li style=\"font-weight: 400\">Chenoweth, M.J., Kim, Y.J., Nollen, N.L, Hawk, L.W., Jr., Mahoney, M.C., Lerman, C., Knight, J., &amp; Tyndale, R.F. (2024). Genetic prediction of smoking cessation medication side effects: A genome-wide investigation of abnormal dreams on varenicline. <em>Clinical Pharmacology &amp; Therapeutics<\/em>, <em>115, <\/em>1277-1281. DOI: <span style=\"text-decoration: underline\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38369951\/\">10.1002\/cpt.3210<\/a><\/span>.<\/li><li style=\"font-weight: 400\">Cooper, R.K., Mahoney, M.C., Tiffany, S.T., Colder, C.R., Tyndale, R.F., &amp; Hawk, L.W., Jr. (2024). Relationships between the nicotine metabolite ratio and laboratory assessments of smoking reinforcement and craving among adults in a smoking cessation trial. <em>Nicotine &amp; Tobacco Research<\/em>, <em>26<\/em>, 604-611. DOI: <span style=\"text-decoration: underline\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37996099\/\">10.1093\/ntr\/ntad232<\/a><\/span>.<\/li><li style=\"font-weight: 400\">Gass, J. C., Tonkin, S., Maguin, E., Colder, C.R., Mahoney, M. C., Tiffany, S. T., &amp; Hawk, L. W., Jr. (2024). A preliminary randomized trial of reinforcement contingencies to improve compliance with ecological momentary assessment. <em>Translational Behavioral Medicine<\/em>, <em>14<\/em>, 60-65. DOI: <span style=\"text-decoration: underline\"><a href=\"https:\/\/doi.org\/10.1093\/tbm\/ibad066\">https:\/\/doi.org\/10.1093\/tbm\/ibad066<\/a><\/span>.<\/li><li style=\"font-weight: 400\">Tonkin, S.S., Gass, J.C., Wray, J.M., Maguin, E., Mahoney, M.C., Colder, C.R., Tiffany, S.T., &amp; Hawk, L.W., Jr. (2023). Evaluating declines in compliance with ecological momentary assessment in longitudinal health behavior research. <em>Journal of Medical Internet Research<\/em>, <em>25<\/em>, e43826. DOI: <span style=\"text-decoration: underline\"><a href=\"https:\/\/doi.org\/10.2196\/43826\">https:\/\/doi.org\/10.2196\/43826<\/a><\/span>.<\/li><li style=\"font-weight: 400\">Ferkin, A.C., Tonkin, S.S., Maguin, E., Mahoney, M.C., Colder, C.R., Tiffany, S.T., &amp; Hawk, L.W., Jr. (2022). A psychometric evaluation of the Stanford Expectations of Treatment Scale (SETS) in the context of a smoking cessation trial. <em>Nicotine &amp; Tobacco Research<\/em>, <em>24<\/em>, 1914-1920<em>.<\/em> DOI: <span style=\"text-decoration: underline\"><a href=\"https:\/\/nam12.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fdoi.org%2F10.1093%2Fntr%2Fntac187&amp;data=05%7C02%7Cgjmerlo%40buffalo.edu%7C95a95c4729a54c904e3508dc8bd0e5f6%7C96464a8af8ed40b199e25f6b50a20250%7C0%7C0%7C638538976544883817%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=ZPPyOyQx3vW%2BRLDRaSqEB1E7xAxJWO%2FdOY70TXJ%2FRYI%3D&amp;reserved=0\" data-outlook-id=\"e0983edc-4eee-4858-a985-12c2ad7efc76\">https:\/\/doi.org\/10.1093\/ntr\/ntac187<\/a><\/span>.<\/li><li style=\"font-weight: 400\">Novalen, M., Chenoweth, M.J., Zhao, B., Hawk, L.W., Jr., Tyndale, R.F. (2022). Stability of varenicline concentration in saliva over twenty-one days at three storage temperatures. <em>Nicotine &amp; Tobacco Research<\/em>, <em>24<\/em>(2), 270-274. DOI:\u00a0<span style=\"text-decoration: underline\"><a href=\"https:\/\/doi.org\/10.1093\/ntr\/ntab173\">https:\/\/doi.org\/10.1093\/ntr\/ntab173<\/a><\/span>. PMID: 34460924.<\/li><li style=\"font-weight: 400\">Lawson, S.C., Gass, J.C., Cooper, R.K., Tonkin, S.S., Colder, C.R., Mahoney, M.C., Tiffany, S.T., &amp; Hawk, L.W., Jr. (2021). The impact of three weeks of pre-quit varenicline on reinforcing value and craving for cigarettes in a laboratory choice procedure. <em>Psychopharmacology, 238<\/em>, 599-609. PMID: 33219852. DOI: <span style=\"text-decoration: underline\"><a href=\"https:\/\/doi.org\/10.1007\/s00213-020-05713-7\">https:\/\/doi.org\/10.1007\/s00213-020-05713-7<\/a><\/span>.<\/li><li style=\"font-weight: 400\">Mahoney, M.C., Park, E., Schlienz, N.J., Duerr, C., &amp; Hawk, L.W. (2021). Transitioning to remote clinic visits in a smoking cessation trial during the SARS coronavirus-2 pandemic: Mixed methods evaluation. <em>JMIR Formative Research, 5(4)<\/em>, e25541<em>.<\/em> DOI: <span style=\"text-decoration: underline\"><a href=\"https:\/\/doi.org\/10.2196\/25541\">https:\/\/doi.org\/10.2196\/25541<\/a><\/span>. PMID: 33878020.<\/li><li style=\"font-weight: 400\">Rosoff-Verbitt, Z., Logue-Chamberlain, E., Fishman, J., Audrain-Mcgovern, J., Hawk, L., Mahoney, M., Mazur, A., &amp; Ashare, R. (2021). The perceived impact of COVID-19 among treatment-seeking smokers: A mixed methods approach.\u00a0<em>International Journal of Environmental Research and Public Health, 18<\/em>(2), 505<em>.<\/em> DOI: <span style=\"text-decoration: underline\"><a href=\"https:\/\/doi.org\/10.3390\/ijerph18020505\">https:\/\/doi.org\/10.3390\/ijerph18020505<\/a><\/span>. Published as part of a special issue: <span style=\"text-decoration: underline\"><a href=\"https:\/\/www.mdpi.com\/journal\/ijerph\/special_issues\/Smoking_Vaping_COVID-19\">https:\/\/www.mdpi.com\/journal\/ijerph\/special_issues\/Smoking_Vaping_COVID-19<\/a><\/span><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-64e0cea e-transform elementor-widget elementor-widget-text-editor\" data-id=\"64e0cea\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_transform_translateX_effect&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;0&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateY_effect&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;37&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateX_effect_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateX_effect_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateY_effect_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;_transform_translateY_effect_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Previous clinical trials in this research line include:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2b808c3 elementor-widget elementor-widget-text-editor\" data-id=\"2b808c3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul style=\"font-weight: 400\"><li>Brandon, T.H., Unrod, M., Drobes D.J., Sutton, S.K., Hawk, L.W., Simmons, V.N., Brandon, K.O., Roetzheim, R.G., Meltzer, L.R., Miller, R.R., &amp; Cahill, S.P. (2018). Facilitated extinction training to improve pharmacotherapy for smoking cessation: A pilot feasibility trial. <em>Nicotine &amp; Tobacco Research, 20, <\/em>1189-1197.\u00a0 <span style=\"text-decoration: underline\"><a href=\"https:\/\/nam12.safelinks.protection.outlook.com\/?url=https%3A%2F%2Facademic.oup.com%2Fntr%2Farticle-abstract%2F20%2F10%2F1189%2F4117259&amp;data=05%7C02%7Cgjmerlo%40buffalo.edu%7C95a95c4729a54c904e3508dc8bd0e5f6%7C96464a8af8ed40b199e25f6b50a20250%7C0%7C0%7C638538976544890446%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=0fLQfnS5%2FY6SkabFUD5BvcJhp8GVaNB72ne6Ht7Xw6g%3D&amp;reserved=0\" data-outlook-id=\"f830ab76-aae1-430f-83f2-3bc1cadbdd53\">DOI: 10.1093\/ntr\/ntx203<\/a><\/span>. PMID: 29059409. <span style=\"text-decoration: underline\"><a href=\"https:\/\/nam12.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7868958%2F&amp;data=05%7C02%7Cgjmerlo%40buffalo.edu%7C95a95c4729a54c904e3508dc8bd0e5f6%7C96464a8af8ed40b199e25f6b50a20250%7C0%7C0%7C638538976544897357%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=mbtjEgqQImdh%2BleRfOCm4u9fqGw5NbCXQjwey605jPM%3D&amp;reserved=0\" data-outlook-id=\"76649e0f-d3cf-4f28-95c0-4c4efecc3ea6\">PMCID: PMC7868958<\/a><\/span>.<\/li><li>Hawk, L.W., Jr., Ashare, R.L., Rhodes, J.D., Oliver, J., Cummings, K.M., &amp; Mahoney, M.C. (2015). Does extended pre-quit bupropion aid in extinguishing smoking behavior? <em>\u00a0Nicotine &amp; Tobacco Research, 17<\/em>(11), 1385-1392. doi:10.1093\/ntr\/ntu347. PMID: 25589680. <span style=\"text-decoration: underline\"><a href=\"https:\/\/nam12.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4612343%2F&amp;data=05%7C02%7Cgjmerlo%40buffalo.edu%7C95a95c4729a54c904e3508dc8bd0e5f6%7C96464a8af8ed40b199e25f6b50a20250%7C0%7C0%7C638538976544904139%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=JbXHl%2B9Yc4rIMS%2BPYBnCZSS8M3L5gKOFd5LWLtqDgog%3D&amp;reserved=0\" data-outlook-id=\"fc623b5b-9556-482a-836f-cbb24be439bb\">PMCID: PMC4612343<\/a><\/span>.<\/li><li>Hawk, L.W., Jr., Ashare, R.L., Lohnes, S.F., Schlienz, N.J., Rhodes, J.D., Tiffany, S.T., Gass, J.C., Cummings, K.M., &amp; Mahoney, M.C. (2012).\u00a0 The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: A randomized clinical trial.\u00a0 <em>Clinical Pharmacology &amp; Therapeutics, 91<\/em>, 172-180<em>. <\/em>DOI:10.1038\/clpt.2011.317 PMCID:<span style=\"text-decoration: underline\"> <a href=\"https:\/\/nam12.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3325094%2F&amp;data=05%7C02%7Cgjmerlo%40buffalo.edu%7C95a95c4729a54c904e3508dc8bd0e5f6%7C96464a8af8ed40b199e25f6b50a20250%7C0%7C0%7C638538976544910836%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&amp;sdata=RYIFGldkKsBdXDJ3u3dRMUv37sHvFzylWX0UWsWn5qQ%3D&amp;reserved=0\" data-outlook-id=\"7c56f2a0-1b16-4a6c-acd7-c3db85dee965\">PMC3325094<\/a><\/span>.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>EVarQuit The EVarQuit2 trials is the latest in a programmatic series of clinical trials led by Dr. Hawk. The overarching goal is to use basic learning principles to enhance quit &hellip; <a href=\"https:\/\/ubwp.buffalo.edu\/hawklab\/evarquit\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">EVarQuit<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":523,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2276","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/ubwp.buffalo.edu\/hawklab\/wp-json\/wp\/v2\/pages\/2276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ubwp.buffalo.edu\/hawklab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ubwp.buffalo.edu\/hawklab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ubwp.buffalo.edu\/hawklab\/wp-json\/wp\/v2\/users\/523"}],"replies":[{"embeddable":true,"href":"https:\/\/ubwp.buffalo.edu\/hawklab\/wp-json\/wp\/v2\/comments?post=2276"}],"version-history":[{"count":24,"href":"https:\/\/ubwp.buffalo.edu\/hawklab\/wp-json\/wp\/v2\/pages\/2276\/revisions"}],"predecessor-version":[{"id":2990,"href":"https:\/\/ubwp.buffalo.edu\/hawklab\/wp-json\/wp\/v2\/pages\/2276\/revisions\/2990"}],"wp:attachment":[{"href":"https:\/\/ubwp.buffalo.edu\/hawklab\/wp-json\/wp\/v2\/media?parent=2276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}